Trastornos autoinmunes y Mieloma Múltiple- Dos Reportes de Casos Ilustrativos y una Revisión de la Literatura

Autores/as

  • Ana María Ávila La Sabana University School of Medicine
  • Sergio Giralt Weill Cornell Medical College

Palabras clave:

Mieloma, Neoplasia, Autoinmunidad, Respuesta a antígeno propio, Inmunobiología, Miastenia

Resumen

Varios trastornos autoinmunes se han asociado a una variedad de neoplasias malignas hematopoyéticas, particularmente trastornos linfoproliferativos. El mieloma múltiple (MM) es una de las neoplasias malignas hematológicas más comunes y ha sido descrito en el contexto de una variedad de condiciones autoinmunes. Debido a su diversidad y rareza, las características clínicas de las condiciones autoinmunes asociadas con el MM no han sido aclaradas y la patogénesis sigue siendo poco clara. En este artículo se describen dos casos de condiciones autoinmunes en el marco del MM y se realiza una revisión de la literatura actual.

Biografía del autor/a

Ana María Ávila, La Sabana University School of Medicine

La Sabana University School of Medicine, Bogota, Colombia

Sergio Giralt, Weill Cornell Medical College

Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States of America

Referencias bibliográficas

Shen K, Xu G, Wu Q, Zhou D, Li J. Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies. PLoS One [Internet]. 2014;9:e91461.

https://doi.org/10.1371/journal.pone.0091461

Benedek TG, Zawadski ZA. Ankylosing spondylitis with ulcerative colitis and amyloidosis. Am Med. 1966;40:431-9.

https://doi.org/10.1016/0002-9343(66)90137-9

Blanc AP, Gastaut JA, Sebahoun G, Carcassonne Y. Association spondylarthrite ankylosante maladie de Kahler: a propos d'une observation. Semin HOp Paris. 1979;55:1335-7.

Danon F, Clauvel JP, Seligmann M. Les ''paraproteines'' de type IgG et IgA en dehors de la maladie de Kahler. Rev Fr Etudes Clin Biol. 1967;12:681-701.

Damali NM, Isis SM, Landgren O. Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk Lymphoma. 2009;50:541-50.

https://doi.org/10.1080/10428190902780677

Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas - An update. J Intern Med. 2008;264:514-27.

https://doi.org/10.1111/j.1365-2796.2008.02029.x

Dimopoulos MA, Kastritis E, Anagnostopoulos A. Hematological malignancies: Myeloma. Ann Oncol. 2006;17 Suppl 10:x137-43.

https://doi.org/10.1093/annonc/mdl251

Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111:3388-94.

https://doi.org/10.1182/blood-2007-10-121285

Dalamaga M, Karmaniolas K, Papadavid E, Pelecanos N, Migdalis I. Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: a case-control study. Leuk Lymphoma [Internet]. 2008;49:1545-52.

https://doi.org/10.1080/10428190802165946

Richardson PG, Weller E, Lonial S, Jakubowiak AJ, Jagannath S, Raje NS, et al. Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma. Blood. 2010;116:679-86.

Rajkumar SV. Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma? ASH Education Book. 2012;2012:354-61.

https://doi.org/10.1182/asheducation.V2012.1.354.3798330

Cho SY, Yang HS, Jeon YL, You E, Lee HJ, Yoon HJ, et al. A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases? Int J Rheum Dis [Internet]. 2014;17:635-9.

https://doi.org/10.1111/1756-185X.12267

Choi JW, Han SW, Kwon KT, Kim GW. Early onset multiple myeloma in a patient with systemic lupus erythematosus: A case report and literature review. Clin Rheumatol [Internet]. 2010;29:1323-6.

https://doi.org/10.1007/s10067-010-1417-3

Waldron-Lynch F, Inzucchi SE, Menard L, Tai N, Preston-Hurlburt P, Hui P, et al. Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma. J Clin Endocrinol Metab [Internet]. 2012;97:4317-23.

https://doi.org/10.1210/jc.2012-2388

Yao H, Monge M, Renou M, Lecaque C, Jauréguy M, Presne C, et al. Thrombotic thrombocytopenic purpura due to anti- ADAMTS13 antibodies in multiple myeloma. Clin Nephrol [Internet]. 2014;81:210-5.

https://doi.org/10.5414/CN107579

García Fernández M, Sanz MA, Vilela C, Rafecas J, Yaya Huaman R. A case of association of myasthenia, thymoma and multiple myeloma. Review of the cases published. Rev Clin Esp. 1979;153:465-9.

Urba'nska-ry's H, Robak E, Kordek R, Bartkowiak J, Rieske P, Wo'zniacka A, et al. Multiple Myeloma in a Patient with Systemic Lupus Erythematosus, Myasthenia Gravis and Non-Familial Diffuse Palmoplantar Keratoderma. Leuk Lymphoma [Internet]. 2004;45:1913-8.

https://doi.org/10.1080/10428190410001663581

Deitcher SR, Erban JK, Limentani SA. Acquired free protein S deficiency associated with multiple myeloma: a case report. Am J Hematol. 1996;51:319-23.

https://doi.org/10.1002/(SICI)1096-8652(199604)51:4<319::AID-AJH12>3.0.CO;2-9

Reza-Ardalan M, Mohajel-Shoja M. Multiple myeloma presented as acute interstitial nephritis and rheumatoid arthritis-like polyarthritis. Am J Hematol. 2007;82:309-13.

https://doi.org/10.1002/ajh.20796

Tazi I, Rachid M, Benchekroun S. Sjögren's syndrome associated with multiple myeloma. Am J Hematol. 2008;49:215-6.

Wang J, Xie X, Li F, Chen J. Multiple myeloma secondary to systemic lupus erythematosus and Sjögren's syndrome: a case report. Arch Rheumatol [Internet]. 2014;29:65-8.

https://doi.org/10.5606/tjr.2014.3326

Alexopoulou A, Dourakis SP, Apostolopoulou A, Kandyli A, Pandelidaki H, Archimandritis AJ. Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis. Clin Rheumatol [Internet]. 2005;24:669-70.

https://doi.org/10.1007/s10067-005-1089-6

Shen M, Ng SC. Multiple myeloma masquerades as rheumatic diseases. Proc Singapore Healthc. 2013;22:64-9.

https://doi.org/10.1177/201010581302200110

Rowland LP, Osserman EF, Scharfman WB, Balsam RF, Ball S. Myasthenia gravis with a myeloma-type, gamma- G (IgG) immunoglobulin abnormality. Am J Med [Internet]. 1969;46:599-605.

https://doi.org/10.1016/0002-9343(69)90078-3

Wada H, Yata K, Mikami M, Suemori S, Nakanishi H, Kondo T, et al. Multiple myeloma complicated by autoimmune hemolytic anemia. Intern Med. 2004;43:595-8.

https://doi.org/10.2169/internalmedicine.43.595

Aryal MR, Bhatt VR, Tandra P, Krishnamurthy J, Yuan J, Greiner TC, et al. Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages? Clin Lymphoma Myeloma Leuk [Internet]. 2014;14:e19-23. Elsevier Inc.

https://doi.org/10.1016/j.clml.2013.08.002

Highet AS. Urticarial vasculitis and IgA myeloma. Br J Dermatol. 1980;102:355-7.

Espa˜na A, Gimenez-Azcarate A, Ishii N, Idoate MA, Panizo C, Hashimoto T. Antidesmocollin 1 autoantibody negative subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma. Br J Dermatol [Internet]. 2015;172:296-8.

https://doi.org/10.1111/bjd.13233

Owlia MB, Distler O, Foratyazdi M, Akhtari M. Visual problem and low back pain as initial manifestation of multiple myeloma complicating pre-existing systemic sclerosis. J Coll Physicians Surg Pakistan [Internet]. 2014;24:S29-31.

Ogg GS, Rosbotham JL, MacDonald DM. Urticaria pigmentosa coexisting with multiple myeloma. Clin Exp Dermatol. 1996;21:365-6.

https://doi.org/10.1111/j.1365-2230.1996.tb00125.x

Tokumitsu S, Yoshio F, Kobayashi T, Tetsuki A, Shinya S, Zensuke O. Complete C1q Deficiency Associated with IgG Multiple Myeloma. Jpn J Med. 1989;28:216-8.

https://doi.org/10.2169/internalmedicine1962.28.216

Chakraverty R, Rabin N, Peggs K, Robinson S, Duncan JR, Yong K. Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemother- apy and autologous peripheral blood stem cell transplantation. Bone Marrow Transpl [Internet]. 2001;27:1215-7.

https://doi.org/10.1038/sj.bmt.1703048

Jain P, Kumar P, Parikh PM. Multiple myeloma with paraneoplastic leucocytoclastic vasculitis. Indian J Cancer. 2009;46:173-4.

https://doi.org/10.4103/0019-509X.49159

Two AM, Li C, Hata T. A case of eosinophilic dermatosis of hematologic malignancy in a patient with multiple myeloma. Dermatol Online J. 2014;20:15.

Radfar L, Fatahzadeh M, Shahamat Y, Sirois D. Paraneoplastic epidermolysis bullosa acquisita associated with multiple myeloma. Spec Care Dent [Internet]. 2006;26:159-63.

https://doi.org/10.1111/j.1754-4505.2006.tb01718.x

Turner RB, Haynes HA, Granter SR, Miller DM. Acquired cutis laxa following urticarial vasculitis associated with IgA myeloma. J Am Acad Dermatol [Internet]. 2009;60:1052-7.

https://doi.org/10.1016/j.jaad.2008.09.059

Zhang Y, Morita E, Matsuo H, Ueda D, Dekio S. Urticarial erythema associated with IgA myeloma. J Dermatol. 2004;31:661-5.

https://doi.org/10.1111/j.1346-8138.2004.tb00573.x

Tabata R, Tabata C, Tazoh A, Nagai T. Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma. Int Immunopharmacol [Internet]. 2012;13:242-4. Elsevier B.V.

https://doi.org/10.1016/j.intimp.2012.04.015

Kashyap R, Singh A, Kumar P. Prevalence of autoimmune hemolytic anemia in multiple myeloma: A prospective study. Asia Pac J Clin Oncol. 2016;2:319-22.

https://doi.org/10.1111/ajco.12230

Srinivasulu N, Sharma V, Samant R. Monoclonal gammopathies presenting as inflammatory arthritis: uncommon but important- a case series. Int J Rheum Dis [Internet]. 2012;15:336-9.

https://doi.org/10.1111/j.1756-185X.2012.01727.x

Frémeaux-Bacchi V, Guinnepain MT, Cacoub P, Dragon-Durey MA, Mouthon L, Blouin J, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med [Internet]. 2002;113:194-9. Elsevier.

https://doi.org/10.1016/S0002-9343(02)01124-5

Collet E, Dalac S, Guy H, Tavernier C, Lorcerie B, Besancenot JF, et al. Manifestations cutanées au cours du myélome multiple. Ann Dermatol Venereol [Internet]. Masson;118(1):35-44.

Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2006;91:5076-82.

https://doi.org/10.1210/jc.2006-1075

Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M. Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica. 2007;92:716-8.

https://doi.org/10.3324/haematol.10769

Caldwell JR, Ruddy S, Schur PH, Austen KF. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1972;1:39-52.

https://doi.org/10.1016/0090-1229(72)90006-2

Benjilali L, Essaadouni L. Un myélome multiple associé à une anémie hémolytique auto-immune. Presse Med [Internet]. 2013;42:1533-5.

https://doi.org/10.1016/j.lpm.2012.11.011

Castelli R, Zanichelli A, Cicardi M, Cugno M. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: A tight relationship. Crit Rev Oncol Hematol [Internet]. 2013;87:323-32. Elsevier Ireland Ltd.

https://doi.org/10.1016/j.critrevonc.2013.02.004

Geha R, Quinti I, Austen F, Gicardi M, Sheffer A, Rosen FS. Acquired C1- Inhibitor Deficiency Associated with Antiidiotypic Antibody to Monoclonal Immunoglobulins. N Engl J Med. 1985:534-40.

https://doi.org/10.1056/NEJM198502283120902

Wu MA, Castelli R. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med. 2016;54:207-14.

https://doi.org/10.1515/cclm-2015-0195

Zeerleder S, Levi M. Hereditary and acquired C1- inhibitordependent angioedema: from pathophysiology to treatment. Ann Med. 2016;48:256-67.

https://doi.org/10.3109/07853890.2016.1162909

Cómo citar

[1]
Ávila, A.M. y Giralt, S. 2018. Trastornos autoinmunes y Mieloma Múltiple- Dos Reportes de Casos Ilustrativos y una Revisión de la Literatura. Revista Colombiana de Cancerología. 22, 2 (jun. 2018), 76–83.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2018-06-01

Número

Sección

Reportes de caso